Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
May 31,2016
Personalized Genomics Dramatically Aids Intellectual Disability Diagnostics
    New findings from clinical studies lead by scientists at British Columbia Children's Hospital, an agency of the Provincial Health Services Authority, and the University of British Columbia, show the life-altering benefits of genome-wide sequencing for children with certain kinds of intellectual disabilities. The results from this study were published recently in the New England JournalRead more
More
Personalized Genomics Dramatically Aids Intellectual Disability Diagnostics
May 31,2016
Bone Marrow Transplant Success Depends on the Dose
    Scientists from the University of Southern California say they have found clues about how the dose of transplanted bone marrow might affect patients undergoing this risky procedure, frequently used to treat cancer and blood diseases.  Specifically, Casey Brewer, Ph.D., and colleagues in the laboratory of Rong Lu, Ph.D., discovered that transplantation dose affects the behaviorRead more
More
May 31,2016
Elisa experimental service (enzyme-linked immunosorbent test)
The basic principle of ELISA The basis of ELISA is the immobilization of antigen or antibody and the enzyme labeling of antigen and antibody. The antigen or antibody bound to the surface of the solid phase carrier still maintains its immunological activity, and the enzyme-labeled antigen or antibody retains both its immunological activity and enzymeRead more
More
Elisa experimental service (enzyme-linked immunosorbent test)
May 30,2016
Vitamin A boosts Pancreatic Cancer Chemotherapy
    During World War II the British government began a disinformation campaign that the Royal Air Force pilots were fed high-carrot diets, giving them superior night vision and the ability to spot the enemy in the dark. In reality, the Allies were doing their best to keep their brand new RADAR technology under wraps. It's unclear howRead more
More
Vitamin A boosts Pancreatic Cancer Chemotherapy
May 30,2016
Venoms Provide Paradoxical Path to Promising Drug Discovery
Investigators led by scientists at The Scripps Research Institute (TSRI) say they have invented a technique for rapidly identifying various venoms that strike a specific target in the body and then optimizing such venoms for therapeutic use. The researchers demonstrated the new method by using it to identify venoms that block a certain protein onRead more
More
May 27,2016
Loss of Y Chromosome is a Risk Factor for Alzheimer Disease
    The loss of the Y chromosome in batches of blood cells over time continues to develop as one biological explanation for why men, on average, live shorter lives than women. An international team of researchers led by scientists at Uppsala University in Sweden presented their recently published findings at the annual conference of the EuropeanRead more
More
May 27,2016
Protein Folding Findings May Lead to Better Therapies for a Range of Human Diseases
    Though research on protein folding has progressed over the past few decades toward better understanding of human metabolism and the diseases associated with misfolding, important discoveries are still being made by teams who can bring special techniques and tools to bear on these complex cellular processes.     Scientists at the University of Massachusetts Amherst report forRead more
More
May 26,2016
Scientists Explain Why Ovarian Cancer Becomes Resistant To Chemotherapy
The reason why ovarian cancer becomes resistant to chemotherapy over a period of time has always fascinated and puzzled the researchers. Now, a team of researchers from the University of Michigan has come up with a possible reason.  The tumor microenvironment is made up of an array of cell types, yet effector T cells andRead more
More
Scientists Explain Why Ovarian Cancer Becomes Resistant To Chemotherapy
May 26,2016
Borrowing Immune Cells Can Help Fight Cancer
A new cancer immunotherapy approach could essentially outsource a crucial T-cell function. This function, T-cell reactivity to specific cancer antigens, is sometimes lacking in cancer patients. Yet, according to a new proof-of-principle study, these patients could benefit from T cells provided by healthy donors. Specifically, the healthy donors' T cells could be used to broadenRead more
More
May 25,2016
Scientists Discover Potential Solution to Antibiotic Resistant Bacteria
    Scientists at Harvard say they have created a new platform for antibiotic discovery that may help solve the crisis of antibiotic resistance. In a study (“A Platform for the Discovery of New Macrolide Antibiotics”) published in Nature, Andrew G. Myers, Ph.D., and colleagues describe “a platform where we assemble eight (chemical) building blocks by a simple processRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->